Status:
RECRUITING
Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
Lead Sponsor:
Can-Am HIFU Inc.
Conditions:
Urologic Diseases
Eligibility:
MALE
18+ years
Brief Summary
To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.
Eligibility Criteria
Inclusion
- Male subjects of ≥ 18 years of age.
- Primary diagnosis of Benign Prostate Hypertrophy (BPH).
- Candidate for Rezūm therapy as per clinical decision of Investigator.
- Willing and able to accurately complete the required questionnaires.
- Willing and able to provide signed and dated informed consent
Exclusion
- Characteristics indicating a poor compliance with study protocol requirements.
- Disease or other health condition that is not suitable for this study.
- Unable or unwilling to provide signed informed consent.
Key Trial Info
Start Date :
October 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05201131
Start Date
October 7 2019
End Date
December 31 2026
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dean Elterman
Toronto, Ontario, Canada, M5T 2S8